Effects of HIV-1 gp120 and protease inhibitors on apoptotic susceptibility of CD34+ hematopoietic progenitor cells

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 2, 2011, Pages

  MacEneaney, Owen J ^a   Connick, Elizabeth ^b   Desouza, Christopher A ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAZANAVIR; CASPASE 3; CD34 ANTIGEN; GLYCOPROTEIN GP 120; LOPINAVIR; PROTEINASE INHIBITOR; RITONAVIR; STAUROSPORINE;

APOPTOSIS; CELL VIABILITY; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOPATHOLOGY; LETTER; PRIORITY JOURNAL;

ANTIGENS, CD34; APOPTOSIS; HEMATOPOIETIC STEM CELLS; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS;

EID: 78751622193     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181fb1cb3     Document Type: Letter

References (16)

1. Banda NK, Simon GR, Sipple JD, et al. Depletion of CD34+ CD4+ cells in bone marrow from HIV-1-infected individuals. Biol Blood Marrow Transplant. 1999;5: 162-172.
2. Scadden DT, Shen H, Cheng T. Hematopoietic stem cells in HIV disease. J Natl Cancer Inst Monogr. 2001;28:24-29.
3. Fadini GP, de Kreutzenberg SV, Coracina A, et al. Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J. 2006;27:2247-2255.
4. Zhang J, Scadden DT, Crumpacker CS. Primitive hematopoietic cells resist HIV-1 infection via p21. J Clin Invest. 2007;117: 473-481.
5. Re MC, Zauli G, Gibellini D, et al. Uninfected haematopoietic progenitor (CD34+) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in culture. AIDS. 1993;7:1049-1055.
6. Zauli G, Re MC, Visani G, et al. Inhibitory effect of HIV-1 envelope glycoproteins gp120 and gp160 on the in vitro growth of enriched (CD34+) hematopoietic progenitor cells. Arch Virol. 1992;122:271-280.
7. Walensky RP, Paltiel AD, Losina E, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006;194: 11-19.
8. Bradbury RA, Samaras K. Antiretroviral therapy and the human immunodeficiency virus-improved survival but at what cost? Diabetes Obes Metab 2008, 10, 441-450.
9. Sloand EM, Maciejewski J, Kumar P, et al. Protease inhibitors stimulate hematopoiesis and decrease apoptosis and ICE expression in CD34(+) cells. Blood. 2000;96: 2735-2739.
10. Adams GB, Pym AS, Poznansky MC, et al. The in vivo effects of combination antiretro-viral drug therapy on peripheral blood CD34+ cell colony-forming units from HIV type 1-infected patients. AIDS Res Hum Retrovi-ruses. 1999;15:551-559.
11. Physicians' Desk Reference. 61st ed. Montvale, NJ: Thomson PDR; 2007.
12. Oh SK, Cruikshank WW, Raina J, et al. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr. 1992;5: 251-256.
13. Zauli G, Re MC, Visani G, et al. Evidence for a human immunodeficiency virus type 1-me-diated suppression of uninfected hematopoietic (CD34+) cells in AIDS patients. J Infect Dis. 1992;166:710-716.
14. Zauli G, Re MC, Furlini G, et al. Human immunodeficiency virus type 1 envelope glyco-protein gp120-mediated killing of human haematopoietic progenitors (CD34+ cells). J Gen Virol. 1992;73(pt 2):417-421.
15. Banda NK, Tomczak JA, Shpall EJ, et al. HIV-gp120 induced cell death in hematopoietic progenitor CD34+ cells. Apoptosis. 1997;2: 61-68.
16. Dam NS, Kjaer EA, Mathiesen L, et al. Highly active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus-infected patients. J Infect Dis. 1998;178:1299-1305.